StonvexLoading…
StonvexStonvexStonvexCore line items from BAC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $113.10B | $105.86B | $102.77B | $94.95B |
Operating Income | $37.70B | $33.22B | $32.53B | $30.97B |
Net Income | $30.51B | $26.97B | $26.30B | $27.53B |
EPS (Diluted) | $3.81 | $3.19 | $3.05 | $3.19 |
Total Assets | $3.41T | $3.26T | $3.18T | $3.05T |
Total Liabilities | $3.11T | $2.97T | $2.89T | $2.78T |
Cash & Equivalents | $231.84B | $290.11B | $333.07B | $230.20B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 7.21B | 7.61B | 7.90B | 8.00B |